SDHA and cardiomyopathy: SDHA mutations cause mitochondrial disease, such as Leigh syndrome (LS) and multisystem (ocular, cardiomyopathy and neurological) disorders, and result in a significant tissue-specific reduction in SDH enzymatic activity, which has been linked to significant clinical phenotypes [52,53,54].